HippoT&C

Startup

home.hippotnc.com/Suwon, South Korea
3 profile visits

About

Founded in 2020, HippoT&C is dedicated to developing digital therapeutics for the diagnosis and treatment of psychological disorders. Our motto, "Elevate positive, mitigate negative" reflects our commitment to analyzing individual patient characteristics and providing tailored treatments. With a focus on leveraging cutting-edge IT technologies, we aim to revolutionize the medical service paradigm for the benefit of both patients and doctors.

We participated in CES 2022, 2023 and achieved Innovation Award in CES 2022 for AttnKare-D.

We are currently focusing on two types of mental disorder : ADHD(Attention-Deficit Hyperactivity Disorder) and MDD(Major Depression Disorder).

ADHD related softwares are AttnKare-D, VR based digital diagnosis software for ADHD children, and AttnKare-T, tablet based digital therapeutics for young ADHD patients.

MDD related softwares are Blukare-T, mobile digital therapeutics with AR functions for MDD patients. Our company is also working on developing BlueKare-D, digital diagnosis software for MDD using biomarkers.

Our company's goals is to combine multiple digital technologies to provide best solutions for mental disorder patients.

Technology

VR/ARDigital Health

Representatives

JoonHui Lee

Researcher/Developer

HippoT&C

Marketplace (1)

  • Service

    AttnKare

    AttnKare is the digital therapeutics for ADHD children. AttnKare is consisted of two solutions : AttnKare-D and AttnKare-T.

    • Others
    • Consulting
    • Distribution
    • Digital Health
    • Research and Development
    Author

    JoonHui Lee

    Researcher/Developer at HippoT&C

    Suwon, South Korea